Improving the Translational Relevance of Animal Models in Cytokine Therapies
Time: 2:00 pm
day: Conference Day Two
Details:
- Exploring the use of novel technologies, such as humanized mice, to create more physiologically relevant models for studying cytokine-mediated effects
- Understanding the importance of considering the tumor microenvironment and the immune context in animal model designs
- Examining STK-012 Phase 1 clinical data: Learning how to improve the translation relevance of the first-in-class α/β IL-2 receptor-biased partial agonist for the treatment of advanced solid tumors
